Clinical Trial Update: E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for E4 FREEDOM evaluating estetrol/drospirenone as an oral contraceptive in the US/Canada; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Estetrol/Drospirenone (Estetrol with drospirenone)

Snippet

Sponsor: Estetra | Conditions: Contraception | Phase 3 | Status: COMPLETED | Results posted: 2019-11-06